Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Philadelphia Financial Management of San Francisco, LLC USAU U.S. Gold Corp. 13G/A 7.95% 3mo
ORBIMED ADVISORS LLC IMUX Immunic, Inc. 13G 5.3% 3mo
Balyasny Asset Management L.P. RACC Research Alliance Corp III 13G 6.43% 3mo
American Century Investment Management, Inc. IBEX IBEX Ltd 13G/A 3.8% 3mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC HDRN Hadron Energy, Inc. 13G/A 0% 3mo
ENDEAVOUR CAPITAL ADVISORS INC FVCB FVCBankcorp, Inc. 13G/A 1.5% 3mo
Jianfeng Xu YALA Yalla Group Ltd 13G/A 8.7% 3mo
SOUTHEASTERN ASSET MANAGEMENT INC/TN/ ESRT Empire State Realty Trust, Inc. 13G 5.1% 3mo
METEORA CAPITAL, LLC TVAI Thayer Ventures Acquisition Corp II 13G/A 2.96% 3mo
Avoro Capital Advisors LLC AVTX Avalo Therapeutics, Inc. 13G/A 4.44% 3mo
John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity TELO Telomir Pharmaceuticals, Inc. 13G/A 5.17% 3mo
Balyasny Asset Management L.P. LXEO Lexeo Therapeutics, Inc. 13G/A 9.99% 3mo
ALLIANCEBERNSTEIN L.P. CVGW Calavo Growers Inc 13G/A 0% 3mo
Driehaus Capital Management LLC CUE Cue Biopharma, Inc. 13G 6.96% 3mo
Maple Rock Capital Partners Inc. WGO Winnebago Industries Inc 13G 5.5% 3mo
American Century Investment Management, Inc. BHE Benchmark Electronics Inc 13G 5.2% 3mo
Polar Asset Management Partners Inc. APUR Aperture AC 13G 7.5% 3mo
Harraden Circle Investments, LLC TMTS Spartacus Acquisition Corp. II 13G/A 3.16% 3mo
Sessa Capital IM, L.P. RNA Atrium Therapeutics, Inc. 13G 8.8% 3mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC DGAC DISCIPLINED GROWTH ACQUISITION Corp 13G 8.5% 3mo
AWM Investment Company, Inc. AEHR Aehr Test Systems 13G/A 1.1% 3mo
AWM Investment Company, Inc. GRO Brazil Potash Corp. 13G/A 9.9% 3mo
INDEX VENTURES LIFE VI (JERSEY) L.P. CNTA Centessa Pharmaceuticals plc 13G/A 0% 3mo
Greenhouse Funds LLLP VYX NCR Voyix Corp 13G/A 17.5% 3mo
Lynx1 Capital Management LP CCCC C4 Therapeutics, Inc. 13G/A 9.99% 3mo
EcoR1 Capital, LLC MREO Mereo BioPharma Group plc 13G/A 0.6% 3mo
Eric M. Mindich BMM Blue Moon Metals Inc. 13G/A 3.5% 3mo
Crestview Partners II GP, L.P. VCTR Victory Capital Holdings, Inc. 13G/A 3.2% 3mo
Fourthstone LLC CARE Carter Bankshares, Inc. 13G/A 0% 3mo
Newtyn Management, LLC NVRI Enviri Corp 13G/A 1.3% 3mo
CoinFund Management LLC ORBS Eightco Holdings Inc. 13G/A 0% 3mo
Philosophy Capital Management LLC HPP Hudson Pacific Properties, Inc. 13G/A 5.4% 3mo
Chirinjeev Kathuria AIRO AIRO Group Holdings, Inc. 13G 14.6% 3mo
T. Rowe Price Investment Management, Inc. USCB Uscb Financial Holdings, Inc. 13G/A 8.6% 3mo
Divisadero Street Capital Management, LP OMDA Omada Health, Inc. 13G/A 6.3% 3mo
COOPER CREEK PARTNERS MANAGEMENT LLC AAP Advance Auto Parts Inc 13G 7.8% 3mo
BAMCO INC /NY/ H Hyatt Hotels Corp 13G/A 17.74% 3mo
T. Rowe Price Investment Management, Inc. PLNT Planet Fitness, Inc. 13G/A 10.5% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ MRX Marex Group Ltd 13G 6.8% 3mo
T. Rowe Price Investment Management, Inc. MLTX MoonLake Immunotherapeutics 13G 5.3% 3mo
Ikarian Capital, LLC NXTC NextCure, Inc. 13G/A 9.99% 3mo
American Century Investment Management, Inc. CMP Compass Minerals International Inc 13G 5.4% 3mo
RTW INVESTMENTS, LP IRTC iRhythm Holdings, Inc. 13G/A 6.6% 3mo
American Century Investment Management, Inc. MATX Matson, Inc. 13G 5.8% 3mo
Balyasny Asset Management L.P. KRRO Korro Bio, Inc. 13G/A 6.6% 3mo
OnePointTwo Capital Ventures II LLC CNXU Conexeu Sciences Inc. 13G 5.5% 3mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC ASBP Aspire-Lakewood Holdings, Inc. 13G/A 0% 3mo
Darwin Global Management, Ltd. INSM INSMED Inc 13G/A 3% 3mo
DARLINGTON PARTNERS CAPITAL MANAGEMENT, LP FUN Six Flags Entertainment Corporation 13G/A 7.5% 3mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC FACT FACT II Acquisition Corp. 13G 8.7% 3mo